SCHEMBL17529331

SCHEMBL17529331

Nc1sc2c(c1C(=O)Nc1ccc(CCc3ccccc3)cc1)CCCC2

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.73
MAPT P10636 8/20 0.69
ALDH1A1 P00352 5/20 0.69
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
ALOX15 P16050 2/20 0.61
ALOX12 P18054 1/20 0.61
TP53 P04637 4/20 0.59
THRB P10828 3/20 0.59
TDP1 Q9NUW8 1/20 0.58
HPGD P15428 2/20 0.57
LMNA P02545 1/20 0.57
GAA P10253 1/20 0.57
ANO1 Q5XXA6 2/20 0.55
FLT3 P36888 1/20 0.55
KDM4E B2RXH2 2/20 0.54
POLB P06746 1/20 0.54
HTT P42858 1/20 0.54
CASP6 P55212 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17529335 0.95 TAAR1 (0.70) TAAR1MAPTALDH1A1MEN1KMT2A
SCHEMBL16681664 0.90 ALOX15 (0.73) TAAR1MAPTALDH1A1MEN1KMT2A
SCHEMBL12176917 0.85 MAPT (0.63) TAAR1MAPTALDH1A1MEN1KMT2A
SCHEMBL15997328 0.85 MAPT (0.62) TAAR1MAPTALDH1A1MEN1KMT2A
SCHEMBL15997433 0.85 MAPT (0.62) TAAR1MAPTALDH1A1MEN1KMT2A
SCHEMBL16420840 0.85 MAPT (0.62) TAAR1MAPTALDH1A1MEN1KMT2A
SCHEMBL8200090 0.84 TAAR1 (1.00) TAAR1MAPTALDH1A1MEN1KMT2A
SCHEMBL28711032 0.83 ALOX15 (0.74) MAPTALDH1A1MEN1KMT2AALOX15
SCHEMBL12297943 0.82 KMT2A (1.00) TAAR1MAPTALDH1A1MEN1KMT2A
SCHEMBL17529373 0.82 TAAR1 (0.53) TAAR1MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107082773-B Sulfate of intestinal 2B type sodium phosphate cotransporter inhibitor and crystal form thereof 江苏恒瑞医药股份有限公司 2020-07-28 CN disclosed
WO-2016026372-A1 THIENOCYCLOALKYL OR THIENOHETEROCYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF IN MEDICINE 江苏恒瑞医药股份有限公司 2016-02-25 WO disclosed